CC
The Chemours Company
Set alert
- YTD
- +14.76%
- 1 year
- +3.13%
- Open
- 12.96
- Prev close
- 13.19
- Mkt cap
- 2.04B
- Vol
- 2.16M
- Avg vol
- 2.29M
- EPS
- -2.02
- P/E
- 0.00
- Div yield
- 2.65%
More statistics
- Low
- 12.98
- High
- 13.58
- Forward P/E
- 7.28
- Beta
- 1.40
- Short ratio
- 7.07
- Inst. own
- 91.33%
- Dividend
- 0.35
- Ex-div date
- Nov 15, 2026
- Earnings
- Nov 2, 2026
- 50-d avg
- 14.27
- 200-d avg
- 18.41
- 1y target
- 16.50
Key statistics
- Market cap
- 2.04B
- Enterprise value
- 5.44B
- Trailing P/E
- 0.00
- Forward P/E
- 7.28
- PEG ratio
- 1.60
- Price / sales
- 0.35
- Price / book
- 0.00
- EPS (TTM)
- -2.02
- Beta
- 1.40
- Dividend yield
- 2.65%
- Payout ratio
- 1666.67%
- Profit margin
- -5.24%
- Revenue (TTM)
- 5.80B
- Revenue growth
- -1.50%
- Free cash flow
- 303.12M
- Total cash
- 671.00M
- Total debt
- 4.12B
- Return on equity
- -319.37%
- Shares outstanding
- 150.50M
- Short % of float
- 13.83%
- 50-day average
- 14.27
- 200-day average
- 18.41
Analyst view
Consensus: hold
- Target (low)
- 14.00
- Target (mean)
- 16.50
- Target (high)
- 20.00
- Strong buy0
- Buy2
- Hold8
- Sell0
- Strong sell0
Next earnings
Nov 2, 2026
Expected Nov 2, 2026. Consensus EPS estimate 0.25771.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 2, 2026 | Sep 30, 2026 | 0.2662 | — | — | — |
| Aug 4, 2026 | Jun 30, 2026 | 0.4887 | 0.42 | -0.07 | -14.06% |
| May 5, 2026 | Mar 31, 2026 | -0.05 | 0.05 | +0.10 | +200.00% |
| Feb 19, 2026 | Dec 31, 2025 | 0.0887 | 0.05 | -0.04 | -43.63% |
| Nov 6, 2025 | Sep 30, 2025 | 0.24 | 0.20 | -0.04 | -16.67% |
| Aug 5, 2025 | Jun 30, 2025 | 0.46 | 0.58 | +0.12 | +26.09% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | Truist Securities | main | Buy | Buy |
| Oct 14, 2026 | Mizuho | down | Outperform | Neutral |
| Oct 13, 2026 | Barclays | init | — | Equal-Weight |
| Oct 5, 2026 | UBS | main | Neutral | Neutral |
| Sep 30, 2026 | Mizuho | main | Outperform | Outperform |
| Aug 13, 2026 | JP Morgan | main | Neutral | Neutral |
About The Chemours Company
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Country
- United States
- Website
- chemours.com
News
- CC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds The Chemours (CC) Investors of Securities Class Action Lawsuit Deadline on December 7, 2026
- Chemours Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Chemours Company - CC
- DEADLINE ALERT for The Chemours Company (CC), Compass, Inc. (COMP), and Millrose Properties, Inc. (MRP): The Law Offices of Frank R. Cruz Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class Actions
- Bronstein, Gewirtz & Grossman LLC Urges Chemours Company Investors to Act: Class Action Filed Alleging Investor Harm
- CC Lawsuit Reminder: Chemours Hit with Securities Fraud Class Action Over Opteon Demand Issues – BFA Law Reminds Investors of the December 7 Deadline
- CC Shareholders Have Rights – If You Lost Money Investing in The Chemours Company Contact Robbins LLP for Information About Recovering Your Losses
- Kaplan Fox Advises The Chemours Company (CC) Investors to Act Before the Lead Plaintiff Deadline on December 7, 2026
- CC SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds The Chemours (CC) Investors of Securities Class Action Lawsuit Deadline on December 7, 2026
- CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law
- Chemours Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Chemours Company - CC
Your note
Sign in to keep a note on CC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CRANSTON MARY B | Director | Purchase | Aug 6, 2026 | 113,141 |
| DIGNAM DENISE | Chief Executive Officer | Purchase | Aug 10, 2026 | 339,916 |
| FAMILIAR CALDERON GERARDO | Officer | Purchase | Aug 11, 2026 | 58,547 |
| FARRELL DAWN LORRAINE | Director | Stock Award(Grant) | Apr 21, 2025 | 97,636 |
| FOLEY MICHAEL ROBERT | Officer | Purchase | Aug 6, 2026 | 80,777 |
| GUMPEL DAMIAN | Officer | Purchase | Jun 2, 2025 | 131,701 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.47% | 23,283,074 | 315.02M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 7.02% | 10,568,867 | 143.00M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.51% | 6,784,588 | 91.80M | Jun 29, 2026 |
| State Street Corporation | 4.06% | 6,115,375 | 82.74M | Jun 29, 2026 |
| Ameriprise Financial, Inc. | 3.27% | 4,924,004 | 66.62M | Jun 29, 2026 |
| American Century Companies Inc | 2.91% | 4,379,525 | 59.25M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 8,958,338 | 121.21M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.18% | 4,783,383 | 64.72M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.64% | 3,976,985 | 53.81M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 3,452,149 | 46.71M | Jun 29, 2026 |
| Columbia Funds Series Trust-Columbia Select Mid Cap Value Fund | 1.52% | 2,281,585 | 30.87M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.45% | 2,184,649 | 29.56M | Jun 29, 2026 |